{"id":"NCT00904670","sponsor":"Pfizer","briefTitle":"Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)","officialTitle":"NWP06 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)- A Laboratory Classroom Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2009-08","completion":"2009-08","firstPosted":"2009-05-20","resultsPosted":"2014-06-26","lastUpdate":"2014-06-26"},"enrollment":45,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention Deficit Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Quillivant Oral Suspension XR","otherNames":["methylphenidate hydrochloride oral suspension"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Active","type":"EXPERIMENTAL"},{"label":"Comparator","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study was to establish that an optimal dose of Quillivant XR oral suspension would result in a significant reduction in signs and symptoms of ADHD compared to placebo treatment in pediatric patients ages 6-12 years with ADHD.","primaryOutcome":{"measure":"Swanson, Kotin, Agler, M-Flynn, and Pelham Rating Scale (SKAMP)-Combined Scores at Hour 4 Post-Dose","timeFrame":"Hour 4 post-dose","effectByArm":[{"arm":"NWP06","deltaMin":7.1,"sd":5.64},{"arm":"Placebo","deltaMin":19.3,"sd":8.38}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["23289899"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=NWP06-ADD-100&StudyName=Quillivant%20Oral%20Suspension%20%28Quillivant%20XR%29%20in%20the%20Treatment%20of%20Attention%20Deficit%20Hyperactivity%20Disorder%20%28ADHD%29"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":45},"commonTop":["Decreased appetite","Abdominal pain upper","Affect lability","Initial insomnia","Insomnia"]}}